- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for the treatment of prostate cancer
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 8, Issue 9, Pages 551-561
Publisher
Springer Nature
Online
2011-05-24
DOI
10.1038/nrclinonc.2011.72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing oncologic benefit in clinical trials of immunotherapy agents
- (2010) R. K. Hales et al. ANNALS OF ONCOLOGY
- Human T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
- (2010) A. Maniar et al. BLOOD
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Anti-prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer
- (2010) Scott T. Tagawa et al. CANCER
- Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients
- (2010) Carlo Sorrentino et al. CLINICAL CANCER RESEARCH
- Castration-Resistant Prostate Cancer
- (2010) Giuseppe Di Lorenzo et al. DRUGS
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research
- (2010) David J. Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
- (2010) Jordan T. Becker et al. JOURNAL OF IMMUNOTHERAPY
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Sipuleucel-T
- (2010) Celestia S. Higano et al. NATURE REVIEWS DRUG DISCOVERY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- New Therapies for Castration-Resistant Prostate Cancer
- (2010) Dan L. Longo NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy for Prostate Cancer: An Emerging Treatment Modality
- (2010) Charles G. Drake UROLOGIC CLINICS OF NORTH AMERICA
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
- (2009) L. Fong et al. CANCER RESEARCH
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- (2009) Hirotsugu Uemura et al. CANCER SCIENCE
- Therapeutic Vaccination with an Interleukin-2–Interferon-γ-Secreting Allogeneic Tumor Vaccine in Patients with Progressive Castration-Resistant Prostate Cancer: A Phase I/II Trial
- (2009) Thomas H. Brill et al. HUMAN GENE THERAPY
- DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
- (2009) Lindsey Low et al. HUMAN GENE THERAPY
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax)
- (2009) Robert J. Amato et al. JOURNAL OF IMMUNOTHERAPY
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy
- (2008) R. A. Madan et al. CLINICAL CANCER RESEARCH
- MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure
- (2008) R. Dreicer et al. INVESTIGATIONAL NEW DRUGS
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Biochemical Recurrence of Prostate Cancer With Granulocyte-Macrophage Colony-Stimulating Factor Secreting, Allogeneic, Cellular Immunotherapy
- (2008) Walter J. Urba et al. JOURNAL OF UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now